Intuitive Surgical, Inc. Operating Lease, Lease Income
Intuitive Surgical, Inc. (ISRG) reported Operating Lease, Lease Income of $261.80 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-21.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseLeaseIncome · last filed 2026-07-21
- Intuitive Surgical, Inc. operating lease, lease income for the quarter ending 2026-06-30 was $261.80M, a 22.45% increase year-over-year.
- Intuitive Surgical, Inc. operating lease, lease income for the quarter ending 2026-03-31 was $250.20M, a 28.18% increase year-over-year.
- Intuitive Surgical, Inc. operating lease, lease income for the quarter ending 2025-12-31 was $242.30M, a 33.50% increase year-over-year.
- Intuitive Surgical, Inc. operating lease, lease income for the quarter ending 2025-09-30 was $223.00M, a 32.90% increase year-over-year.
- Intuitive Surgical, Inc. operating lease, lease income for fiscal 2025 was $874.30M, a 33.64% increase from fiscal 2024.
- Intuitive Surgical, Inc. operating lease, lease income for fiscal 2024 was $654.20M, a 30.71% increase from fiscal 2023.
- Intuitive Surgical, Inc. operating lease, lease income for fiscal 2023 was $500.50M, a 32.93% increase from fiscal 2022.
- Intuitive Surgical, Inc. operating lease, lease income for fiscal 2022 was $376.50M, a 35.97% increase from fiscal 2021.
| Period end | Operating Lease, Lease Income 3 month | Operating Lease, Lease Income 3 month as first filed | Operating Lease, Lease Income 6 month | Operating Lease, Lease Income 9 month | Operating Lease, Lease Income 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $261.80M 10-Q · filed 2026-07-21 | $512.00M 10-Q · filed 2026-07-21 | $754.30M derived: sum of 3 quarters · filed 2026-07-21 | $977.30M derived: sum of 4 quarters · filed 2026-07-21 | |
| 2026-03-31 | $250.20M 10-Q · filed 2026-04-22 | $492.50M derived: sum of 2 quarters · filed 2026-04-22 | $715.50M derived: sum of 3 quarters · filed 2026-04-22 | $929.30M derived: sum of 4 quarters · filed 2026-07-21 | |
| 2025-12-31 | $242.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $465.30M derived: sum of 2 quarters · filed 2026-02-03 | $679.10M derived: sum of 3 quarters · filed 2026-07-21 | $874.30M 10-K · filed 2026-02-03 | |
| 2025-09-30 | $223.00M 10-Q · filed 2025-10-22 | $436.80M derived: sum of 2 quarters · filed 2026-07-21 | $632.00M 10-Q · filed 2025-10-22 | $813.50M derived: sum of 4 quarters · filed 2026-07-21 | |
| 2025-06-30 | $213.80M 10-Q · filed 2026-07-21 | $409.00M 10-Q · filed 2026-07-21 | $590.50M derived: sum of 3 quarters · filed 2026-07-21 | $758.30M derived: sum of 4 quarters · filed 2026-07-21 | |
| 2025-03-31 | $195.20M 10-Q · filed 2026-04-22 | $376.70M derived: sum of 2 quarters · filed 2026-04-22 | $544.50M derived: sum of 3 quarters · filed 2026-04-22 | $701.40M derived: sum of 4 quarters · filed 2026-04-22 | |
| 2024-12-31 | $181.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $349.30M derived: sum of 2 quarters · filed 2026-02-03 | $506.20M derived: sum of 3 quarters · filed 2026-02-03 | $654.20M 10-K · filed 2026-02-03 | |
| 2024-09-30 | $167.80M 10-Q · filed 2025-10-22 | $324.70M derived: sum of 2 quarters · filed 2025-10-22 | $472.70M 10-Q · filed 2025-10-22 | $611.40M derived: sum of 4 quarters · filed 2026-02-03 | |
| 2024-06-30 | $156.90M 10-Q · filed 2025-07-23 | $304.90M 10-Q · filed 2025-07-23 | $443.60M derived: sum of 3 quarters · filed 2026-02-03 | $570.70M derived: sum of 4 quarters · filed 2026-02-03 | |
| 2024-03-31 | $148.00M 10-Q · filed 2025-04-23 | $286.70M derived: sum of 2 quarters · filed 2026-02-03 | $413.80M derived: sum of 3 quarters · filed 2026-02-03 | $536.50M derived: sum of 4 quarters · filed 2026-02-03 | |
| 2023-12-31 | $138.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $265.80M derived: sum of 2 quarters · filed 2026-02-03 | $388.50M derived: sum of 3 quarters · filed 2026-02-03 | $500.50M 10-K · filed 2026-02-03 | |
| 2023-09-30 | $127.10M 10-Q · filed 2024-10-18 | $249.80M derived: sum of 2 quarters · filed 2024-10-18 | $361.80M 10-Q · filed 2024-10-18 | $464.60M derived: sum of 4 quarters · filed 2025-01-31 | |
| 2023-06-30 | $122.70M 10-Q · filed 2024-07-19 | $234.70M 10-Q · filed 2024-07-19 | $337.50M derived: sum of 3 quarters · filed 2025-01-31 | $435.00M derived: sum of 4 quarters · filed 2025-01-31 | |
| 2023-03-31 | $112.00M 10-Q · filed 2024-04-19 | $214.80M derived: sum of 2 quarters · filed 2025-01-31 | $312.30M derived: sum of 3 quarters · filed 2025-01-31 | $405.30M derived: sum of 4 quarters · filed 2025-01-31 | |
| 2022-12-31 | $102.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-31 | $200.30M derived: sum of 2 quarters · filed 2025-01-31 | $293.30M derived: sum of 3 quarters · filed 2025-01-31 | $376.50M 10-K · filed 2025-01-31 | |
| 2022-09-30 | $97.50M 10-Q · filed 2023-10-20 | $190.50M derived: sum of 2 quarters · filed 2023-10-20 | $273.70M 10-Q · filed 2023-10-20 | $351.80M derived: sum of 4 quarters · filed 2024-01-31 | |
| 2022-06-30 | $93.00M 10-Q · filed 2023-07-24 | $176.20M 10-Q · filed 2023-07-24 | $254.30M derived: sum of 3 quarters · filed 2024-01-31 | $326.80M derived: sum of 4 quarters · filed 2024-01-31 | |
| 2022-03-31 | $83.20M 10-Q · filed 2023-04-20 | $161.30M derived: sum of 2 quarters · filed 2024-01-31 | $233.80M derived: sum of 3 quarters · filed 2024-01-31 | $301.10M derived: sum of 4 quarters · filed 2024-01-31 | |
| 2021-12-31 | $78.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-31 | $150.60M derived: sum of 2 quarters · filed 2024-01-31 | $217.90M derived: sum of 3 quarters · filed 2024-01-31 | $276.90M 10-K · filed 2024-01-31 | |
| 2021-09-30 | $72.50M 10-Q · filed 2022-10-21 | $139.80M derived: sum of 2 quarters · filed 2022-10-21 | $198.80M 10-Q · filed 2022-10-21 | $248.50M derived: sum of 4 quarters · filed 2023-02-10 | |
| 2021-06-30 | $67.30M 10-Q · filed 2022-07-22 | $126.30M 10-Q · filed 2022-07-22 | $176.00M derived: sum of 3 quarters · filed 2023-02-10 | $221.70M derived: sum of 4 quarters · filed 2023-02-10 | |
| 2021-03-31 | $59.00M 10-Q · filed 2022-04-22 | $108.70M derived: sum of 2 quarters · filed 2023-02-10 | $154.40M derived: sum of 3 quarters · filed 2023-02-10 | $196.60M derived: sum of 4 quarters · filed 2023-02-10 | |
| 2020-12-31 | $49.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $95.40M derived: sum of 2 quarters · filed 2023-02-10 | $137.60M derived: sum of 3 quarters · filed 2023-02-10 | $176.70M 10-K · filed 2023-02-10 | |
| 2020-09-30 | $45.70M 10-Q · filed 2021-10-20 | $87.90M derived: sum of 2 quarters · filed 2021-10-20 | $127.00M 10-Q · filed 2021-10-20 | $161.00M derived: sum of 4 quarters · filed 2022-02-03 | |
| 2020-06-30 | $42.20M 10-Q · filed 2021-07-21 | $81.30M 10-Q · filed 2021-07-21 | $115.30M derived: sum of 3 quarters · filed 2022-02-03 | $142.70M derived: sum of 4 quarters · filed 2022-02-03 | |
| 2020-03-31 | $39.10M 10-Q · filed 2021-04-21 | $73.10M derived: sum of 2 quarters · filed 2022-02-03 | $100.50M derived: sum of 3 quarters · filed 2022-02-03 | $125.60M derived: sum of 4 quarters · filed 2022-02-03 | |
| 2019-12-31 | $34.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $61.40M derived: sum of 2 quarters · filed 2022-02-03 | $86.50M derived: sum of 3 quarters · filed 2022-02-03 | $106.90M 10-K · filed 2022-02-03 | |
| 2019-09-30 | $27.40M 10-Q · filed 2020-10-19 | $52.50M derived: sum of 2 quarters · filed 2020-10-19 | $72.90M 10-Q · filed 2020-10-19 | $89.30M derived: sum of 4 quarters · filed 2021-02-10 | |
| 2019-06-30 | $25.10M 10-Q · filed 2020-07-23 | $45.50M 10-Q · filed 2020-07-23 | $61.90M derived: sum of 3 quarters · filed 2021-02-10 | $75.90M derived: sum of 4 quarters · filed 2021-02-10 | |
| 2019-03-31 | $20.40M 10-Q · filed 2020-04-17 | $4.60M 10-Q · filed 2019-04-19 | $36.80M derived: sum of 2 quarters · filed 2021-02-10 | $50.80M derived: sum of 3 quarters · filed 2021-02-10 | $62.30M derived: sum of 4 quarters · filed 2021-02-10 |
| 2018-12-31 | $16.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $30.40M derived: sum of 2 quarters · filed 2021-02-10 | $41.90M derived: sum of 3 quarters · filed 2021-02-10 | $51.40M 10-K · filed 2021-02-10 | |
| 2018-09-30 | $14.00M 10-Q · filed 2019-10-18 | $25.50M derived: sum of 2 quarters · filed 2019-10-18 | $35.00M 10-Q · filed 2019-10-18 | ||
| 2018-06-30 | $11.50M 10-Q · filed 2019-07-22 | $21.00M 10-Q · filed 2019-07-22 | |||
| 2018-03-31 | $12.00M 10-Q · filed 2019-04-19 | ||||
| 2017-12-31 | $25.90M 10-K · filed 2020-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |